Yu, W.; Wu, X.; Zhao, Y.; Chen, C.; Yang, Z.; Zhang, X.; Ren, J.; Wang, Y.; Wu, C.; Li, C.;
et al. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Molecules 2021, 26, 7385.
https://doi.org/10.3390/molecules26237385
AMA Style
Yu W, Wu X, Zhao Y, Chen C, Yang Z, Zhang X, Ren J, Wang Y, Wu C, Li C,
et al. Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Molecules. 2021; 26(23):7385.
https://doi.org/10.3390/molecules26237385
Chicago/Turabian Style
Yu, Wei, Xiaomin Wu, Yizhen Zhao, Chun Chen, Zhiwei Yang, Xiaochun Zhang, Jiayi Ren, Yueming Wang, Changwen Wu, Chengming Li,
and et al. 2021. "Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design" Molecules 26, no. 23: 7385.
https://doi.org/10.3390/molecules26237385
APA Style
Yu, W., Wu, X., Zhao, Y., Chen, C., Yang, Z., Zhang, X., Ren, J., Wang, Y., Wu, C., Li, C., Chen, R., Wang, X., Zheng, W., Liao, H., & Yuan, X.
(2021). Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design. Molecules, 26(23), 7385.
https://doi.org/10.3390/molecules26237385